AbCellera Biologics Inc vs ProShares Ultra Bloomberg Natural Gas ETF — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while ProShares Ultra Bloomberg Natural Gas ETF trades at $21. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | BOIL | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $9.76 | $87.24 |
52-Week Low | $2.78 | $18.74 |
Enterprise Value | $2.58B | — |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →